- Company Directors - C
- Colella Samuel D
Insider Trading History of Colella Samuel D
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Colella Samuel D since 2006.
The trader's CIK number is 1201580.
At the time of the last reporting, Colella Samuel D was the Director of Fluidigm Corp. (stock ticker symbol FLDM).
Also see all insider trading activities at Fluidigm Corp.
Note that in the past
COLELLA SAMUEL D also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genomic Health Inc (GHDX) by Colella Samuel D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | GHDX | 0 | $0 | 56,910 | $1,691,800 | 0 | $0 |
| 2011 | GHDX | 0 | $0 | 34,320 | $873,444 | 0 | $0 |
| 2010 | GHDX | 0 | $0 | 106,700 | $2,074,907 | 0 | $0 |
Yearly summary of insider trading at Fluidigm Corp (FLDM) by Colella Samuel D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | FLDM | 20,000 | $54,289 | 0 | $0 | 0 | $0 |
| 2019 | FLDM | 12,000 | $80,066 | 0 | $0 | 23,600 | $146,862 |
| 2018 | FLDM | 0 | $0 | 0 | $0 | 15,848 | $0 |
| 2017 | FLDM | 53,395 | $193,764 | 0 | $0 | 12,848 | $0 |
| 2016 | FLDM | 25,000 | $163,415 | 0 | $0 | 0 | $0 |
| 2015 | FLDM | 0 | $0 | 53,340 | $2,076,216 | 53,340 | $600,373 |
| 2013 | FLDM | 0 | $0 | 23,192 | $461,822 | 0 | $0 |
Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (NOVC) by Colella Samuel D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | NOVC | 230,769 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Flexion Therapeutics Inc (FLXN) by Colella Samuel D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | FLXN | 2,000 | $21,480 | 0 | $0 | 0 | $0 |
| 2017 | FLXN | 5,000 | $85,050 | 0 | $0 | 0 | $0 |
| 2016 | FLXN | 773,122 | $10,950,070 | 0 | $0 | 0 | $0 |
| 2014 | FLXN | 307,692 | $3,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ) by Colella Samuel D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | JAZZ | 0 | $0 | 0 | $0 | 55,000 | $771,540 |
| 2008 | JAZZ | 296,022 | $0 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Colella Samuel D:
1. Genomic Health Inc (GHDX)
2. Fluidigm Corp (FLDM)
3. Paratek Pharmaceuticals, Inc. (NOVC)
4. Flexion Therapeutics Inc (FLXN)
5. Jazz Pharmaceuticals Plc (JAZZ)
Table 1. Insider trading of Genomic Health Inc (GHDX) by Colella Samuel D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-11-19 | GHDX | Sale | 25,116 | 26.97 | 677,478 |
| 2012-11-20 | GHDX | Sale | 5,500 | 26.52 | 145,843 |
| 2012-05-17 | GHDX | Sale | 16,994 | 33.52 | 569,689 |
| 2012-05-18 | GHDX | Sale | 9,300 | 32.13 | 298,790 |
| 2011-03-03 | GHDX | Sale | 34,320 | 25.45 | 873,444 |
| 2010-03-09 | GHDX | Sale | 60,000 | 19.63 | 1,177,800 |
| 2010-03-10 | GHDX | Sale | 46,700 | 19.21 | 897,107 |
Table 2. Insider trading of Fluidigm Corp (FLDM) by Colella Samuel D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-10 | FLDM | Buy | 10,000 | 2.77 | 27,740 |
| 2020-03-11 | FLDM | Buy | 10,000 | 2.65 | 26,549 |
| 2019-08-27 | FLDM | Buy | 2,000 | 5.19 | 10,372 |
| 2019-08-08 | FLDM | Buy | 1,000 | 6.65 | 6,653 |
| 2019-08-07 | FLDM | Buy | 1,000 | 6.86 | 6,857 |
| 2019-08-06 | FLDM | Buy | 8,000 | 7.02 | 56,184 |
| 2019-06-20 | FLDM | Option Ex | 23,600 | 6.22 | 146,862 |
| 2018-05-30 | FLDM | Option Ex | 8,000 | .00 | 0 |
| 2017-12-31 | FLDM | Option Ex | 7,848 | .00 | 0 |
| 2017-09-30 | FLDM | Option Ex | 7,848 | .00 | 0 |
| 2017-08-08 | FLDM | Buy | 35,895 | 2.77 | 99,357 |
| 2017-07-31 | FLDM | Option Ex | 5,000 | .00 | 0 |
| 2017-05-09 | FLDM | Buy | 7,500 | 5.92 | 44,437 |
| 2017-03-14 | FLDM | Buy | 10,000 | 5.00 | 49,970 |
| 2016-12-14 | FLDM | Buy | 5,000 | 7.39 | 36,935 |
| 2016-11-30 | FLDM | Buy | 20,000 | 6.32 | 126,480 |
| 2015-02-19 | FLDM | Option Ex | 38,840 | 11.18 | 434,231 |
| 2015-02-20 | FLDM | Option Ex | 5,700 | 4.45 | 25,342 |
| 2015-02-19 | FLDM | Sale | 38,840 | 38.97 | 1,513,711 |
| 2015-02-20 | FLDM | Sale | 5,700 | 38.92 | 221,849 |
| 2015-02-18 | FLDM | Option Ex | 8,800 | 16.00 | 140,800 |
| 2015-02-18 | FLDM | Sale | 8,800 | 38.71 | 340,656 |
| 2013-08-13 | FLDM | Sale | 8,903 | 19.95 | 177,614 |
| 2013-08-14 | FLDM | Sale | 14,289 | 19.89 | 284,208 |
Table 3. Insider trading of Paratek Pharmaceuticals, Inc. (NOVC) by Colella Samuel D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-15 | NOVC | Buy | 230,769 | .00 | 0 |
Table 4. Insider trading of Flexion Therapeutics Inc (FLXN) by Colella Samuel D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-08-08 | FLXN | Buy | 2,000 | 10.74 | 21,480 |
| 2017-06-05 | FLXN | Buy | 5,000 | 17.01 | 85,050 |
| 2016-11-21 | FLXN | Buy | 33,333 | 18.00 | 599,994 |
| 2016-06-20 | FLXN | Buy | 6,778 | 13.84 | 93,821 |
| 2016-06-21 | FLXN | Buy | 18,726 | 13.69 | 256,265 |
| 2016-06-08 | FLXN | Buy | 714,285 | 14.00 | 9,999,990 |
| 2014-02-18 | FLXN | Buy | 307,692 | 13.00 | 3,999,996 |
Table 5. Insider trading of Jazz Pharmaceuticals Plc (JAZZ) by Colella Samuel D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-01-11 | JAZZ | Option Ex | 55,000 | 14.03 | 771,540 |
| 2008-07-21 | JAZZ | Buy | 296,022 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Colella Samuel D
(Director of Fluidigm Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.